Catalyst Wire Dossier Catalyst Wire Dossier

Kyomarc

bevacizumab · Amgen Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kyomarc, covering 2017-11-10 to 2017-11-10. Get the full timeline:

Most recent: EMA Application withdrawn: Kyomarc (bevacizumab) — Amgen Europe B.V.

See pricing